Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising effects. However, the cost of this innovative drug and its supply have become key topics for patients and healthcare professionals. While tirzepatide has been approved by regulatory agencies, its expensive nature presents a significant barrier to many. D